Exagen, Inc. (XGN)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Exagen, Inc. (XGN)
Go deeper and ask any question about XGN
Company Performance
Current Price
as of Sep 13, 2024$2.96
P/E Ratio
N/A
Market Cap
$51.46M
Description
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Metrics
Overview
- HQVista, CA
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerXGN
- Price$2.96-1.66%
Trading Information
- Market Cap$51.46M
- Float47.37%
- Average Daily Volume (1m)44,199
- Average Daily Volume (3m)56,024
- EPS-$0.97
Company
- Revenue$56.66M
- Rev Growth (1yr)6.56%
- Net Income-$2.97M
- Gross Margin60.12%
- EBITDA Margin-14.33%
- EBITDA-$2.16M
- EV$32.48M
- EV/Revenue0.57
- P/EN/A
- P/S0.95
Documents
SEC Filings
Earnings Calls
Factset Street Account